The Northeast usually hoggs the spotlight for medical innovation. Texas follows close behind. California thinks it’s the capital of the future. South Carolina? Not so much.
That’s changing. Fast.
A new pilot program called In Our DNA SC is spreading across the Palmetto State. It isn’t sticking to the fancy clinics in Charleston. It’s reaching rural backroads, small towns, and places the rest of the medical world often ignores. The goal? Preventive care based on your actual DNA.
50,000 South Carolinians are participating in the first phase. They are getting screened for inherited risks tied to three specific killers: breast cancer, colon cancer, and heart disease.
Here is why this matters. About 1 in 60 participants carries a treatable genetic risk. Most people don’t know they have it until it’s too late. This program changes the timeline. It moves the conversation from “why me” to “how do we stop it.”
What The In Our DNA SC Program Actually Looks For
Most people think genetic testing is for celebrities with breast cancer. Or maybe you think it’s just for Ancestry.com hobbyists. The In Our DNA SC program flips that script.
It focuses on conditions listed by the Centers for Disease Control and prevention. Specifically, it targets three inherited problems with clear intervention paths.
First, Lynch syndrome. This gene variant drives a significant share of colon and uterine cancers. If you know you have it, you start colonoscopies decades earlier than the general public. You catch the pre-cancerous stuff and cut it out. Done.
Second, hereditary breast and ovarian cancer. Think BRCA mutations. If a woman knows her status, she might start MRIs and mammograms in her twenties. Some might even choose preventive surgery. It’s heavy. It’s also life-saving.
Third, familial hypercholesterolemia. This is the bad cholesterol kind. The kind that kills you in middle age despite a “healthy” diet. Finding this early means statin therapy could start in adolescence. Not after the first heart attack.
Why Population Genetic Screening Beats Traditional Methods
Traditional genetics is reactive. You get sick. Or your mom gets sick. Or three aunts get sick. Then a specialist tells you to take a blood test.
This is population screening. It’s proactive. You don’t need a family history. You don’t need symptoms. You just need to live in South Carolina and want to know.
The Medical University of South Carolina designed three easy ways to get in on this.
- Visit a clinic. Give blood.
- Show up at a community event. Partners included local churches, public health groups, and health systems.
- Ask for a mailer. A saliva kit arrives at your door. Swish a cheek swab. Mail it back.
The samples go to Helix, a genomics company helping sequence the DNA. Results land in your medical record in weeks. No waiting room nightmares. Just data.
How The Program Reaches Rural And Underserved Areas
This is where the data gets interesting.
Participation wasn’t clustered in Greenville or Charleston. Enrollments came from all 46 counties. From the coast to the foothills.
When you adjust for population size, urban and rural participation rates matched up. Even in areas the CDC marks as socially vulnerable—places with fewer providers, less transport, and lower income—people signed up.
Why?
Older reference databases for DNA are white, wealthy, and European. Variants look scary in one population but common in another. By including diverse groups from across South Carolina, the results become more accurate for everyone.
Technology is easy. Reaching people is hard.
The program knew this. People in rural areas or marginalized communities often trust no one when it comes to health data. And for good reason. History is littered with misuse.
The team countered this with transparency. They explained how data is deidentified for research. They didn’t use jargon. If someone tests positive for a condition, they get free genetic counseling. Not a bill. A counselor to explain what the results mean for their family.
What Happens After The Test Results Arrive
Does it work?
The answer from the first phase of In Our DNA SC is a loud yes. The pilot proved you can reach a diverse, largely rural state with public genomic screening.
It’s a model. Florida is doing similar work with newborns, sequencing babies at birth. South Carolina is focusing on adults. Both represent early steps toward a system where your genetic destiny isn’t a fixed sentence.
It’s a starting point.
Imagine a world where identifying inherited risk is routine. Like a flu shot. Or a vision test. We aren’t there yet. But the roadmap is drawn.
Other states are watching. Maybe even other nations. If this succeeds, we’re looking at fewer preventable deaths. Better care. And a shift in how we treat disease before it even has a chance to start.
What’s left is seeing if other places will follow suit. Or if this stays a Southern experiment for a little longer.
